Drawing for MAGMARIS

USPTO serial 79177447

MAGMARIS

Reviewed by CopyMark Law Group

Reg. 4990928Status 404
Filing date
Status date
Registration date
Jul 5, 2016
Examiner
LOBO, DEBORAH E
Law office
PUBLICATION AND ISSUE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with MAGMARIS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Jennifer Fraser

Jennifer Fraser DYKEMA GOSSETT PLLC1301 K Street, NWSuite 1100 WestWashington, DC 20005

Goods and services

ClassDescriptionStatusFirst use
005Chemical and pharmaceutical preparations for medical use, namely, for treatment of vascular and cardiovascular diseases; organic and inorganic chemical and pharmaceutical preparations, namely, for treatment of vascular and cardiovascular diseases; chemical and pharmaceutical preparations for medical use, namely, inorganic preparations for the treatment of vascular and cardiovascular diseases; pharmaceutical preparations used in medical engineering, namely, drug delivery agents in the form of coatings for medical apparatus that facilitate the delivery of a wide range of active pharmaceutical ingredients; pharmaceuticals preparations, namely, drug delivery agents in form of coatings for stents and implants containing active pharmaceutical ingredients; chemical preparations for pharmaceutical or medical purposes, namely, drug delivery agents for enhancing the biocompatibility of implants in the form of coatings for stents; chemical preparations for pharmaceutical or medical purposes, namely, drug delivery agents for enhancing the healing of implants in the form of coatings for stents; medicines for the treatment of vascular and cardiovascular diseases; medical preparations for the treatment of vascular and cardiovascular diseases; medicines for the treatment of vascular and cardiovascular diseases; medicines and medicine preparations for the treatment of heart diseaseSECTION 71 - CANCELLED—
010Surgical and medical apparatus and instruments, namely, vascular and cardiovascular implants and apparatus; stents, catheters, flexible stents, stents containing the active ingredients, Drug Eluting Stents (DES), absorbable stents, metal stents, Bare Metal Stents (BMS); coronary stents, namely, implantable absorbable scaffolds comprising artificial materials for maintaining tissue contour; implantable scaffolds comprising artificial materials for maintaining tissue contour and also containing an active pharmaceutical ingredient; implantable metal coronary scaffolds for maintaining tissue contourSECTION 71 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Mar 19, 2026DENANOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED—
Mar 19, 2026DETHDEATH OF INTERNATIONAL REGISTRATION—
Aug 7, 2025NREPNEW REPRESENTATIVE AT IB RECEIVED—
Oct 16, 2023INNTTOTAL INVALIDATION PROCESSED BY THE IB—
Sep 27, 2023INTSTOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB—
Sep 27, 2023INPCINVALIDATION PROCESSED—
Sep 20, 2023INTRTOTAL INVALIDATION OF REG EXT PROTECTION CREATED—
Jan 20, 2023C71TCANCELLED SECTION 71—
Jul 5, 2021REM3COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED—
Jun 5, 2021NREPNEW REPRESENTATIVE AT IB RECEIVED—
Dec 16, 2016FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Oct 25, 2016FICSFINAL DISPOSITION NOTICE SENT TO IB—
Oct 25, 2016FIMPFINAL DISPOSITION PROCESSED—
Oct 5, 2016FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Jul 5, 2016R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jun 28, 2016TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Apr 19, 2016NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Apr 19, 2016PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Mar 30, 2016NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Mar 16, 2016PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Mar 16, 2016CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Mar 16, 2016XAECEXAMINER'S AMENDMENT ENTERED—
Mar 16, 2016GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Mar 16, 2016GNEAEXAMINERS AMENDMENT E-MAILED—
Mar 16, 2016CNEAEXAMINERS AMENDMENT -WRITTEN—
Mar 14, 2016TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Mar 14, 2016CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Mar 7, 2016ALIEASSIGNED TO LIE—
Feb 25, 2016TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Feb 19, 2016NREPNEW REPRESENTATIVE AT IB RECEIVED—
Jan 8, 2016RFNTREFUSAL PROCESSED BY IB—
Dec 18, 2015RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Dec 18, 2015RFRRREFUSAL PROCESSED BY MPU—
Dec 18, 2015RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Dec 17, 2015CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 15, 2015DOCKASSIGNED TO EXAMINER—
Dec 8, 2015MAFRAPPLICATION FILING RECEIPT MAILED—
Dec 4, 2015NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Dec 3, 2015REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance